cultivate(MD) is an innovative new model for medical technology investment. It drives maximum value, while minimizing capital input.

The cultivate(MD) model is already yielding a harvest, with multiple products entering the market.

Learn More >>>

cultivate post

Portfolio Companies

Genesis Innovation Group is continuously seeking and investigating medical device technologies where our team can complement the creation of value. We are focused on early stage where our team can add value through addition of technical competence, talented team members, and financial resources.

Genesis Software Innovations
Embody, Inc.
imascap genesis portfolio2
Imascap SAS
iMAGEN genesis portfolio
Magnesium Development Company genesis portfolio
Magnesium Development Company
shoulder innovations genesis
Shoulder Innovations

If you are interested in learning more about future investment opportunities, or becoming a strategic partner with us in this trillion dollar healthcare economy, please connect with us.

Section subtitle

Latest News

OMTEC 2019 Rob Ball

Rob Ball – Keynote Panelist at OMTEC 2019

Rob Ball, CEO of Genesis Innovation Group will be a Keynote Panelist at OMTEC 2019. Event Information State and Future of the Orthopedic Industry: Device Executive Perspective Wednesday, June 12, …